Coronary flow velocity reserve is impaired in hypertensive patients with hyperhomocysteinemia

J Liu1, Y Xu1, H Zhang1

  • 1Department of Endocrinology, Beijing Chaoyang Hospital Affiliated to Capital Medical University, Beijing, People's Republic of China.

Insights

High homocysteine (HHcy) levels combined with hypertension significantly impair coronary artery endothelial function. This damage may be linked to insulin resistance, highlighting a critical link between HHcy, hypertension, and cardiovascular health.

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Syndrome

Background:

  • Hyperhomocysteinemia (HHcy) is a known risk factor for coronary artery disease.
  • Homocysteine (Hcy) impacts insulin sensitivity and can cause endoplasmic reticulum stress in adipose tissue.
  • The combined impact of chronic HHcy and hypertension on coronary artery endothelial function remains unclear.

Purpose of the Study:

  • To investigate the combined effects of chronic HHcy and hypertension on coronary artery endothelial function.
  • To assess the relationship between Hcy levels, insulin resistance, and endothelial function in hypertensive patients.

Main Methods:

  • Fifty-one patients with essential hypertension (HT) were divided into groups with (H-type HT) and without (nHT) HHcy.
  • Forty healthy subjects served as controls.
  • Coronary artery endothelial function was assessed using coronary flow velocity reserve (CFVR).
  • Insulin resistance was evaluated using the homeostasis model assessment (HOMA-IR).

Main Results:

  • Hypertensive patients exhibited higher Hcy levels and lower CFVR compared to controls.
  • Hcy levels were negatively correlated with CFVR.
  • The H-type HT group showed significantly higher insulin resistance and lower CFVR compared to the nHT group.
  • Coronary artery endothelial function was impaired in hypertensive patients with HHcy.

Conclusions:

  • Combined chronic HHcy and hypertension impair coronary artery endothelial function.
  • Insulin resistance induced by HHcy may contribute to endothelial dysfunction in hypertensive patients.
  • These findings suggest a significant interplay between HHcy, hypertension, insulin resistance, and cardiovascular health.

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.3K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
765
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.8K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.9K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.8K